M
Munther A. Khamashta
Researcher at King's College London
Publications - 638
Citations - 56004
Munther A. Khamashta is an academic researcher from King's College London. The author has contributed to research in topics: Antiphospholipid syndrome & Lupus erythematosus. The author has an hindex of 109, co-authored 623 publications receiving 50205 citations. Previous affiliations of Munther A. Khamashta include University College London & University of Córdoba (Spain).
Papers
More filters
Journal ArticleDOI
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri,Ana Maria Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Melissa Costner,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Guillermo Ruiz-Irastorza,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Peter J. Maddison,Mary Anne Dooley,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,Jeffrey P. Callen,S. Sam Lim,Barri J. Fessler,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks,Lisa Sigler,Suhail Hameed,Hong Fang,Ngoc Minh Pham,Robin L. Brey,Michael H. Weisman,Gerald McGwin,Laurence S. Magder +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.
Wendell A. Wilson,Azzudin E. Gharavi,Takao Koike,Michael D. Lockshin,D. Ware Branch,J.C. Piette,Robin L. Brey,Ronald H. W. M. Derksen,E. Nigel Harris,Graham R. V. Hughes,Douglas A. Triplett,Munther A. Khamashta +11 more
Journal ArticleDOI
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Ricard Cervera,J.C. Piette,Josep Font,Munther A. Khamashta,Yehuda Shoenfeld,María Teresa Camps,Søren Jacobsen,Gabriella Lakos,Angela Tincani,Irene Kontopoulou-Griva,Mauro Galeazzi,Pier Luigi Meroni,Ronald H. W. M. Derksen,Philip G. de Groot,Erika Gromnica-Ihle,Marta Baleva,Marta Mosca,Stefano Bombardieri,Frédéric Houssiau,Jean-Christophe Gris,Isabelle Quéré,Eric Hachulla,Carlos Vasconcelos,B. Roch,Antonio Fernández-Nebro,Marie Claire Boffa,Graham R. V. Hughes,Miguel Ingelmo +27 more
TL;DR: An association with SLE, the patient's sex, and the patient’s age at disease onset can modify the disease expression and define specific subsets of APS.
Journal ArticleDOI
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
Munther A. Khamashta,Maria José Cuadrado,Fedza Mujic,Nick Taub,Beverley J. Hunt,Graham R. V. Hughes +5 more
TL;DR: The risk of recurrent thrombosis in patients with the antiphospholipid-antibody syndrome is high and long-term anticoagulation therapy in which the international normalized ratio is maintained at or above 3 is advisable in these patients.
Journal ArticleDOI
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
Ricard Cervera,Munther A. Khamashta,Josep Font,Gian Domenico Sebastiani,Antonio Gil,Lavilla P,Juan Carlos Mejía,A. Olcay Aydintug,Hanna Chwalinska-Sadowska,Enrique de Ramón,Antonio Fernández-Nebro,Mauro Galeazzi,Merete Valen,Alessandro Mathieu,Frédéric Houssiau,Natividad Caro,Paula Alba,Manuel Ramos-Casals,Miguel Ingelmo,Graham R. V. Hughes +19 more
TL;DR: In this paper, the authors assessed the frequency and characteristics of the main causes of morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and compared the frequency of early manifestations with those that appeared later in the evolution of the disease.